Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Building a national framework for the establishment of regulatory science for drug development [[electronic resource] ] : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs
| Building a national framework for the establishment of regulatory science for drug development [[electronic resource] ] : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (95 p.) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
LebovitzYeonwoo
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Pharmaceutical policy - United States
Drug development - Government policy - United States Pharmaceutical industry - Government policy - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-01910-8
9786613019103 0-309-15890-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies"" |
| Record Nr. | UNINA-9910457137103321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Building a national framework for the establishment of regulatory science for drug development [[electronic resource] ] : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs
| Building a national framework for the establishment of regulatory science for drug development [[electronic resource] ] : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (95 p.) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
LebovitzYeonwoo
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Pharmaceutical policy - United States
Drug development - Government policy - United States Pharmaceutical industry - Government policy - United States |
| ISBN |
0-309-20959-5
1-283-01910-8 9786613019103 0-309-15890-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies"" |
| Record Nr. | UNINA-9910781299503321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Building a national framework for the establishment of regulatory science for drug development : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs
| Building a national framework for the establishment of regulatory science for drug development : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academies Press, , 2011 |
| Descrizione fisica | 1 online resource (95 pages) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
LebovitzYeonwoo
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Pharmaceutical policy - United States
Drug development - Government policy - United States Pharmaceutical industry - Government policy - United States |
| ISBN |
0-309-20959-5
1-283-01910-8 9786613019103 0-309-15890-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies"" |
| Record Nr. | UNINA-9910828319503321 |
| Washington, D.C. : , : National Academies Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Envisioning a transformed clinical trials enterprise in the United States [[electronic resource] ] : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy
| Envisioning a transformed clinical trials enterprise in the United States [[electronic resource] ] : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy |
| Pubbl/distr/stampa | Washington, : National Academies Press, 2012 |
| Descrizione fisica | 1 online resource (232 p.) |
| Disciplina | 615.50724 |
| Altri autori (Persone) |
WeisfeldNeil E
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Clinical trials - United States
Clinical medicine - Research - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-63636-0
0-309-25316-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 Integrating Community Practice and Clinical Trials""; ""3 Improving Public Participation in Clinical Trials""; ""4 Creating a New Business Model for Clinical Trials""; ""5 Building an Infrastructure to Support Clinical Trials""; ""6 Suggesting an Agenda for Transforming Elements of the Clinical Trials Enterprise""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies""; ""Appendix C: Registered Workshop Attendees""
""Appendix D: Discussion Paper: The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation""""Appendix E: Discussion Paper: Developing a Robust Clinical Trials Workforce""; ""Appendix F: Discussion Paper: Transforming the Economics of Clinical Trials""; ""Appendix G: Discussion Paper: Developing a Clinical Trials Infrastructure""; ""Appendix H: Discussion Paper: Canadian Strategy on Patient-Oriented Research""; ""Appendix I: Discussion Paper: Health Research as a Public Good""; ""Appendix J: Discussion Paper: Novel Ways to Get Good Trial Data: The UK Experience"" ""Appendix K: IOM Staff Paper: Context and Glossary of Select Terms Associated with the Clinical Trials Enterprise"" |
| Record Nr. | UNINA-9910462082103321 |
| Washington, : National Academies Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Envisioning a transformed clinical trials enterprise in the United States [[electronic resource] ] : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy
| Envisioning a transformed clinical trials enterprise in the United States [[electronic resource] ] : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy |
| Pubbl/distr/stampa | Washington, : National Academies Press, 2012 |
| Descrizione fisica | 1 online resource (232 p.) |
| Disciplina | 615.50724 |
| Altri autori (Persone) |
WeisfeldNeil E
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Clinical trials - United States
Clinical medicine - Research - United States |
| ISBN |
0-309-25318-7
1-283-63636-0 0-309-25316-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 Integrating Community Practice and Clinical Trials""; ""3 Improving Public Participation in Clinical Trials""; ""4 Creating a New Business Model for Clinical Trials""; ""5 Building an Infrastructure to Support Clinical Trials""; ""6 Suggesting an Agenda for Transforming Elements of the Clinical Trials Enterprise""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies""; ""Appendix C: Registered Workshop Attendees""
""Appendix D: Discussion Paper: The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation""""Appendix E: Discussion Paper: Developing a Robust Clinical Trials Workforce""; ""Appendix F: Discussion Paper: Transforming the Economics of Clinical Trials""; ""Appendix G: Discussion Paper: Developing a Clinical Trials Infrastructure""; ""Appendix H: Discussion Paper: Canadian Strategy on Patient-Oriented Research""; ""Appendix I: Discussion Paper: Health Research as a Public Good""; ""Appendix J: Discussion Paper: Novel Ways to Get Good Trial Data: The UK Experience"" ""Appendix K: IOM Staff Paper: Context and Glossary of Select Terms Associated with the Clinical Trials Enterprise"" |
| Record Nr. | UNINA-9910785914603321 |
| Washington, : National Academies Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy
| Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, : National Academies Press, 2012 |
| Descrizione fisica | 1 online resource (232 p.) |
| Disciplina | 615.50724 |
| Altri autori (Persone) |
WeisfeldNeil E
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Clinical trials - United States
Clinical medicine - Research - United States |
| ISBN |
0-309-25318-7
1-283-63636-0 0-309-25316-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 Integrating Community Practice and Clinical Trials""; ""3 Improving Public Participation in Clinical Trials""; ""4 Creating a New Business Model for Clinical Trials""; ""5 Building an Infrastructure to Support Clinical Trials""; ""6 Suggesting an Agenda for Transforming Elements of the Clinical Trials Enterprise""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies""; ""Appendix C: Registered Workshop Attendees""
""Appendix D: Discussion Paper: The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation""""Appendix E: Discussion Paper: Developing a Robust Clinical Trials Workforce""; ""Appendix F: Discussion Paper: Transforming the Economics of Clinical Trials""; ""Appendix G: Discussion Paper: Developing a Clinical Trials Infrastructure""; ""Appendix H: Discussion Paper: Canadian Strategy on Patient-Oriented Research""; ""Appendix I: Discussion Paper: Health Research as a Public Good""; ""Appendix J: Discussion Paper: Novel Ways to Get Good Trial Data: The UK Experience"" ""Appendix K: IOM Staff Paper: Context and Glossary of Select Terms Associated with the Clinical Trials Enterprise"" |
| Record Nr. | UNINA-9910823345703321 |
| Washington, : National Academies Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Public engagement and clinical trials [[electronic resource] ] : new models and disruptive technologies : workshop summary / / Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Public engagement and clinical trials [[electronic resource] ] : new models and disruptive technologies : workshop summary / / Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (115 p.) |
| Disciplina | 610.72/4 |
| Altri autori (Persone) |
WeisfeldVictoria
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico | Clinical trials |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-31196-8
9786613311962 0-309-21930-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910457376103321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Public engagement and clinical trials [[electronic resource] ] : new models and disruptive technologies : workshop summary / / Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Public engagement and clinical trials [[electronic resource] ] : new models and disruptive technologies : workshop summary / / Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (115 p.) |
| Disciplina | 610.72/4 |
| Altri autori (Persone) |
WeisfeldVictoria
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico | Clinical trials |
| ISBN |
0-309-21932-9
1-283-31196-8 9786613311962 0-309-21930-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Recruitment challenges in clinical trials for different diseases and conditions -- Models for public engagement -- Messages and methods for public engagement -- The media -- Novel clinical trials designs -- The health system's structure and culture -- Toward a patient-centered strategy for clinical trials. |
| Record Nr. | UNINA-9910781954003321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Public engagement and clinical trials : new models and disruptive technologies : workshop summary / / Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Public engagement and clinical trials : new models and disruptive technologies : workshop summary / / Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (115 p.) |
| Disciplina | 610.72/4 |
| Altri autori (Persone) |
WeisfeldVictoria
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico | Clinical trials |
| ISBN |
0-309-21932-9
1-283-31196-8 9786613311962 0-309-21930-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Recruitment challenges in clinical trials for different diseases and conditions -- Models for public engagement -- Messages and methods for public engagement -- The media -- Novel clinical trials designs -- The health system's structure and culture -- Toward a patient-centered strategy for clinical trials. |
| Record Nr. | UNINA-9910814853603321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Transforming clinical research in the United States [[electronic resource] ] : challenges and opportunities : workshop summary / / Rebecca A. English, Yeanwoo Lebovitz, and Robert B. Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Transforming clinical research in the United States [[electronic resource] ] : challenges and opportunities : workshop summary / / Rebecca A. English, Yeanwoo Lebovitz, and Robert B. Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2010 |
| Descrizione fisica | xvii, 131 p. : ill. (some col.), col. maps |
| Disciplina | 610.72/4 |
| Altri autori (Persone) |
EnglishRebecca A
LebovitzYeonwoo GiffinRobert B |
| Soggetto topico |
Clinical trials - United States
Clinical trials - Research - United States Clinical trials - Government policy - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-91702-1
9786612917028 0-309-15333-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910465666103321 |
| Washington, D.C., : National Academies Press, c2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
